Hsbc Holdings PLC Esperion Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 21,979 shares of ESPR stock, worth $40,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,979

Previous 25,655 14.33%

Holding current value

$40,001

Previous $42,000 14.29%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.61 - $3.83 $5,918 - $14,079	-3,676 Reduced 14.33%	21,979 $48,000
Q3 2024 Nov 14, 2024	BUY	$1.61 - $2.73 $41,304 - $70,038	25,655 New	25,655 $42,000
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $1,144 - $1,707	-210 Reduced 1.12%	18,516 $125,000
Q2 2022 Aug 11, 2022	SELL	$4.77 - $6.67 $15,216 - $21,277	-3,190 Reduced 14.56%	18,726 $118,000
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $73,199 - $121,852	21,916 New	21,916 $103,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $28.71 $177,005 - $261,950	-9,124 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$25.12 - $36.89 $104,097 - $152,872	-4,144 Reduced 31.23%	9,124 $255,000
Q4 2020 Feb 12, 2021	BUY	$24.2 - $35.76 $94,234 - $139,249	3,894 Added 41.54%	13,268 $344,000
Q3 2020 Nov 12, 2020	SELL	$31.18 - $52.71 $6.27 Million - $10.6 Million	-201,236 Reduced 95.55%	9,374 $352,000
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $239,689 - $409,402	7,979 Added 3.94%	210,610 $10.8 Million
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $272,204 - $732,492	9,920 Added 5.15%	202,631 $6.46 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $5.76 Million - $9.73 Million	162,711 Added 542.37%	192,711 $11.6 Million
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $851,477 - $1.17 Million	-24,702 Reduced 45.16%	30,000 $1.1 Million
Q2 2019 Aug 13, 2019	SELL	$40.1 - $52.33 $2.75 Million - $3.59 Million	-68,632 Reduced 55.65%	54,702 $2.55 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $4.7 Million - $6.28 Million	-117,256 Reduced 48.74%	123,334 $4.95 Million
Q4 2018 Feb 13, 2019	BUY	$36.99 - $59.11 $8.9 Million - $14.2 Million	240,590 New	240,590 $11.1 Million

Others Institutions Holding ESPR

# of Institutions

215

Shares Held

129M

Call Options Held

1.78M

Put Options Held

1.27M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $121M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Esperion Therapeutics, Inc. Transaction History